Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,840
Closed -$256K 522
2020
Q4
$256K Sell
1,840
-900
-33% -$113K 0.03% 367
2020
Q3
$306K Hold
2,740
0.04% 291
2020
Q2
$255K Sell
2,740
-1,100
-29% -$93.6K 0.04% 317
2020
Q1
$282K Sell
3,840
-155
-4% -$13.5K 0.05% 246
2019
Q4
$336K Sell
3,995
-60
-1% -$4.64K 0.06% 228
2019
Q3
$341K Hold
4,055
0.07% 217
2019
Q2
$265K Hold
4,055
0.05% 258
2019
Q1
$239K Sell
4,055
-1,000
-20% -$59.7K 0.05% 298
2018
Q4
$268K Hold
5,055
0.06% 260
2018
Q3
$303K Sell
5,055
-125
-2% -$6.84K 0.06% 272
2018
Q2
$223K Buy
+5,180
New +$209K 0.05% 362

Other funds holding MEDP

Caprock Group's MEDP Position: Q1 2021 in Review

Caprock Group sold out of Medpace (MEDP) in Q1 2021, closing a stake of 1,840 shares — an estimated $256K sold.

Caprock Group first reported a position in MEDP in Q2 2018 and held it in 11 quarters. The position peaked at $341K in Q3 2019. 319 funds tracked by Wall St. Rank hold MEDP as of Q1 2021.

  • Caprock Group reported no remaining Medpace position as of Q1 2021 after selling out during the quarter.
  • Caprock Group sold 1,840 Medpace shares in Q1 2021, an estimated $256K.
  • Caprock Group first reported a position in Medpace in Q2 2018 and held it in 11 quarters.
  • Caprock Group's Medpace position peaked at $341K in Q3 2019.
  • 319 funds tracked by Wall St. Rank held Medpace as of Q1 2021.

Based on Caprock Group's 13F filing for Q1 2021, filed 29 Apr 2021.